- HealthTech
- Tuesday, 09 Jun 2020
WuXi Biologics Signs Lease for a Clinical Manufacturing Facility in the United States
The new clinical manufacturing facility will install total 6000 L bioreactors, Process Development (PD), Quality Control (QC) labs, along with supporting functions. The 66,000-square-foot facility is expected to become operational in late 2020 and will bring in up to 100 jobs to the region.
This news follows WuXi Biologics' recent purchase of land to build a new 107,000-square-foot clinical and commercial manufacturing facility in Worcester, Massachusetts, and the lease of a 33,000-square-foot site to establish a process development lab in King of Prussia, Pennsylvania.
"We are excited to announce our third site in the United States and proud to become a member of the New Jersey community. Cranbury is a growing hub for the biotech and biopharma industries, and we look forward to working with and serving our partners in the area to benefit patients worldwide," said Dr. Chris Chen, CEO of WuXi Biologics.
Related Industry Updates
Vakrangee Limited (VL) enables free registration for the virtual medical consultation service vHealth by Aetna in 10,000 Vakrangee Kendras for 30 days
Apr 27, 2020
Chronic Disease Management Market Size (Value & Volume), Future Trends, Opportunities and Sales Channels, Forecast 2027 By Allscripts , ScienceSoft USA Corporation , Siemens Healthcare Private Limited , Koninklijke Philips N.V ,
Apr 08, 2021
Asia Pacific OTC Drug and Dietary Supplement Market 2020 Demands, Applications, Trends, Pricing, Sales & Investments up to 2027| Business Market Insights
Mar 09, 2021
Research details developments in the Medical Record Management Market future scenario by 2027
Mar 23, 2021
Autoimmune Treatment Market Set To Grow According To Forecasts Due To Increasing Prevalence Of Obesity
Jan 04, 2021
GAIA and Daiichi Sankyo Europe Partner to Launch Digital Therapeutics
Mar 10, 2026
Explore why South Africa Anti-Infective Market is Thriving Worldwide 2020-2027 with an increase in Revenue of $2572.5Mn
Aug 11, 2020